Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases

Clinical article

Restricted access

Object

The aim of this study was to identify potential risk factors for and determine the rate of vertebral compression fracture (VCF) after intensity-modulated, near-simultaneous, CT image–guided stereotactic body radiotherapy (SBRT) for spinal metastases.

Methods

The study group consisted of 123 vertebral bodies (VBs) in 93 patients enrolled in prospective protocols for metastatic disease. Data from these patients were retrospectively analyzed. Stereotactic body radiotherapy consisted of 1, 3, or 5 fractions for overall median doses of 18, 27, and 30 Gy, respectively. Magnetic resonance imaging studies, obtained at baseline and at each follow-up, were evaluated for VCFs, tumor involvement, and radiographic progression. Self-reported average pain levels were scored based on the 11-point (0–10) Brief Pain Inventory both at baseline and at follow-up. Obesity was defined as a body mass index ≥ 30.

Results

The median imaging follow-up was 14.9 months (range 1–71 months). Twenty-five new or progressing fractures (20%) were identified, and the median time to progression was 3 months after SBRT. The most common histologies included renal cancer (36 VBs, 10 fractures, 10 tumor progressions), breast cancer (20 VBs, 0 fractures, 5 tumor progressions), thyroid cancer (14 VBs, 1 fracture, 2 tumor progressions), non–small cell lung cancer (13 VBs, 3 fractures, 3 tumor progressions), and sarcoma (9 VBs, 2 fractures, 2 tumor progressions). Fifteen VBs were treated with kyphoplasty or vertebroplasty after SBRT, with 5 procedures done for preexisting VCFs. Tumor progression was noted in 32 locations (26%) with 5 months' median time to progression. At the time of noted fracture progression there was a trend toward higher average pain scores but no significant change in the median value. Univariate logistic regression showed that an age > 55 years (HR 6.05, 95% CI 2.1–17.47), a preexisting fracture (HR 5.05, 95% CI 1.94–13.16), baseline pain and narcotic use before SBRT (pain: HR 1.31, 95% CI 1.06–1.62; narcotic: HR 2.98, 95% CI 1.17–7.56) and after SBRT (pain: HR 1.34, 95% CI 1.06–1.70; narcotic: HR 3.63, 95% CI 1.41–9.29) were statistically significant predictors of fracture progression. On multivariate analysis an age > 55 years (HR 10.66, 95% CI 2.81–40.36), a preexisting fracture (HR 9.17, 95% CI 2.31–36.43), and baseline pain (HR 1.41, 95% CI 1.05–1.9) were found to be significant risks, whereas obesity (HR 0.02, 95% CI 0–0.2) was protective.

Conclusions

Stereotactic body radiotherapy is associated with a significant risk (20%) of VCF. Risk factors for VCF include an age > 55 years, a preexisting fracture, and baseline pain. These risk factors may aid in the selection of which spinal SBRT patients should be considered for prophylactic vertebral stabilization or augmentation procedures. Clinical trial registration no.: NCT00508443.

Article Information

Address correspondence to: Eric L. Chang, M.D., Department of Radiation Oncology, University of Southern California, Keck School of Medicine, 1441 Eastlake Avenue, NOR G-356, Los Angeles, California 90033-0804. email: eric.chang@med.usc.edu.

Please include this information when citing this paper: published online January 6, 2012; DOI: 10.3171/2011.11.SPINE116.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Bar graphs demonstrating fractured VBs (black) as a proportion of total VBs treated (gray) in location along the spinal axis (A), lytic versus sclerotic/mixed appearance on CT (B), VB involvement (C), and most common histologies (D).

  • View in gallery

    Kaplan-Meier plots comparing various factors. A: Age > 55 versus ≤ 55 years (HR 4.98, 95% CI 2.25–11.00, p < 0.01). B: Lytic versus sclerotic/mixed appearance on CT (HR 2.25, 95% CI 1.02–4.96, p < 0.05). C: Preexisting fracture versus none (HR 9.53, 95% CI 3.32–27.33, p < 0.01). D: Radiographic evidence of tumor progression versus stable disease (HR 3.22, 95% CI 1.22–8.50, p < 0.02).

References

1

Black DMCummings SRKarpf DBCauley JAThompson DENevitt MC: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:153515411996

2

Burton AWReddy SKShah HNTremont-Lukats IMendel E: Percutaneous vertebroplasty—a technique to treat refractory spinal pain in the setting of advanced metastatic cancer: a case series. J Pain Symptom Manage 30:87952005

3

Burton AWRhines LDMendel E: Vertebroplasty and kyphoplasty: a comprehensive review. Neurosurg Focus 18:3e12005

4

Calmels VVallée JNRose MChiras J: Osteoblastic and mixed spinal metastases: evaluation of the analgesic efficacy of percutaneous vertebroplasty. AJNR Am J Neuroradiol 28:5705742007

5

Chang ELShiu ASMendel EMathews LAMahajan AAllen PK: Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7:1511602007

6

Cleeland CSRyan KM: Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:1291381994

7

Dimar JR IIVoor MJZhang YMGlassman SD: A human cadaver model for determination of pathologic fracture threshold resulting from tumorous destruction of the vertebral body. Spine (Phila Pa 1976) 23:120912141998

8

Ebihara HIto MAbumi KTaneichi HKotani YMinami A: A biomechanical analysis of metastatic vertebral collapse of the thoracic spine: a sheep model study. Spine (Phila Pa 1976) 29:9949992004

9

Ettinger BBlack DMNevitt MCRundle ACCauley JACummings SR: Contribution of vertebral deformities to chronic back pain and disability. J Bone Miner Res 7:4494561992

10

Fisher CGDiPaola CPRyken TCBilsky MHShaffrey CIBerven SH: A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 35:E1221E12292010

11

Fourney DRFrangou EMRyken TCDipaola CPShaffrey CIBerven SH: Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 29:307230772011

12

Fourney DRSchomer DFNader RChlan-Fourney JSuki DAhrar K: Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 98:1 Suppl21302003

13

Gagnon GJNasr NMLiao JJMolzahn IMarsh DMcRae D: Treatment of spinal tumors using cyberknife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients. Neurosurgery 64:2973072009

14

Georgy BA: Metastatic spinal lesions: state-of-the-art treatment options and future trends. AJNR Am J Neuroradiol 29:160516112008

15

Gerszten PCBurton SAOzhasoglu CWelch WC: Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32:1931992007

16

Gerszten PCGermanwala ABurton SAWelch WCOzhasoglu CVogel WJ: Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. J Neurosurg Spine 3:2963012005

17

Gerszten PCMendel EYamada Y: Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes?. Spine (Phila Pa 1976) 34:22 SupplS78S922009

18

Gibbs ICKamnerdsupaphon PRyu MRDodd RKiernan MChang SD: Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 82:1851902007

19

Gilbert HAKagan ARNussbaum HRao ARSatzman JChan P: Evaluation of radiation therapy for bone metastases: pain relief and quality of life. AJR Am J Roentgenol 129:109510961977

20

Hentschel SJBurton AWFourney DRRhines LDMendel E: Percutaneous vertebroplasty and kyphoplasty performed at a cancer center: refuting proposed contraindications. J Neurosurg Spine 2:4364402005

21

Jacobs WBPerrin RG: Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus 11:6e102001

22

Jensen MEKallmes DE: Percutaneous vertebroplasty in the treatment of malignant spine disease. Cancer J 8:1942062002

23

Jin JYChen QJin RRock JAnderson JLi S: Technical and clinical experience with spine radiosurgery: a new technology for management of localized spine metastases. Technol Cancer Res Treat 6:1271332007

24

Kado DMBrowner WSPalermo LNevitt MCGenant HKCummings SR: Vertebral fractures and mortality in older women: a prospective study. Arch Intern Med 159:121512201999

25

Klazen CALohle PNde Vries JJansen FHTielbeek AVBlonk MC: Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet 376:108510922010

26

Klimo P JrSchmidt MH: Surgical management of spinal metastases. Oncologist 9:1881962004

27

Lindsay RSilverman SLCooper CHanley DABarton IBroy SB: Risk of new vertebral fracture in the year following a fracture. JAMA 285:3203232001

28

Maranzano ELatini P: Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys 32:9599671995

29

Oakland RJFurtado NRTimothy JHall RM: The biomechanics of vertebroplasty in multiple myeloma and metastatic bladder cancer: a preliminary cadaveric investigation. Laboratory investigation. J Neurosurg Spine 9:4935012008

30

O'Neill TWCockerill WMatthis CRaspe HHLunt MCooper C: Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int 15:7607652004

31

Pierce SMRecht ALingos TIAbner AVicini FSilver B: Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23:9159231992

32

Rades DFehlauer FSchulte RVeninga TStalpers LJBasic H: Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 24:338833932006

33

Rose PSLaufer IBoland PJHanover ABilsky MHYamada J: Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 27:507550792009

34

Roy DKO'Neill TWFinn JDLunt MSilman AJFelsenberg D: Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 14:19262003

35

Ryu SJin JYJin RRock JAjlouni MMovsas B: Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 109:6286362007

36

Ryu SRock JRosenblum MKim JH: Patterns of failure after single-dose radiosurgery for spinal metastasis. J Neurosurg 101:Suppl 34024052004

37

Sahgal AMa LGibbs IGerszten PCRyu SSoltys S: Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 77:5485532010

38

Shah ANPietrobon RRichardson WJMyers BS: Patterns of tumor spread and risk of fracture and epidural impingement in metastatic vertebrae. J Spinal Disord Tech 16:83892003

39

Sheehan JPShaffrey CISchlesinger DWilliams BJArlet VLarner J: Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. Neurosurgery 65:105210622009

40

Shiu ASChang ELYe JSLii MRhines LDMendel E: Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int J Radiat Oncol Biol Phys 57:6056132003

41

Silverman SL: The clinical consequences of vertebral compression fracture. Bone 13:Suppl 2S27S311992

42

Snyder BDCordio MANazarian AKwak SDChang DJEntezari V: Noninvasive Prediction of Fracture Risk in Patients with Metastatic Cancer to the Spine. Clin Cancer Res 15:767676832009

43

Taneichi HKaneda KTakeda NAbumi KSatoh S: Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine. Spine (Phila Pa 1976) 22:2392451997

44

Tsai JTLin JWChiu WTChu WC: Assessment of image-guided CyberKnife radiosurgery for metastatic spine tumors. J Neurooncol 94:1191272009

45

Weber MHBurch SBuckley JSchmidt MHFehlings MGVrionis FD: Instability and impending instability of the thoracolumbar spine in patients with spinal metastases: a systematic review. Int J Oncol 38:5122011

46

Yamada YBilsky MHLovelock DMVenkatraman ESToner SJohnson J: High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71:4844902008

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 99 99 41
Full Text Views 156 156 51
PDF Downloads 124 124 13
EPUB Downloads 0 0 0

PubMed

Google Scholar